RNU1-104P

Across TCGA pan-cancer cohorts, RNU1-104P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU1-104P data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RNU1-104P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU1-104P expression acts as an unfavorable survival marker.

BRCA, LUSC, and LIHC are the cancer types where RNU1-104P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	All	0.663	0.904	<.001	90	view →
LUSC	OS	Tertile	All	0.252	0.762	.016	54	view →
LIHC	OS	Tertile	All	0.164	0.704	.025	18	view →
SARC	DFS	Tertile	All	0.148	0.613	.007	18	view →
PRAD	DFS	Tertile	All	0.213	0.775	.049	12	view →
LGG	OS	Tertile	All	0.324	0.799	.018	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU1-104P–BRCA (DFS)

Open the BRCA breakdown →